NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT00000843

Locations: 🇺🇸
UCSF / Moffitt Hosp - Pediatric, San Francisco, California, United States
🇺🇸
Vanderbilt Univ Med Ctr, Nashville, Tennessee, United States
🇺🇸
Chicago Children's Memorial Hosp, Chicago, Illinois, United States

and more 7 locations

A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 12

Registration Number: NCT00000852

Locations: 🇺🇸
Univ Hosp of Cleveland / Case Western Reserve Univ, Cleveland, Ohio, United States

An HIV Vaccine Preparedness Study

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 4892

Registration Number: NCT00000915

Locations: 🇺🇸
Bronx Lebanon Hosp Ctr, Bronx, New York, United States
🇺🇸
New York Blood Ctr, Bronx, New York, United States
🇺🇸
Univ of Pennsylvania / HIVNET, Philadelphia, Pennsylvania, United States

and more 5 locations

A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 32

Registration Number: NCT00000798

Locations: 🇺🇸
Johns Hopkins Univ / Ctr for Immunological Research, Baltimore, Maryland, United States
🇺🇸
Univ of Rochester Med Ctr, Rochester, New York, United States

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 30

Registration Number: NCT00000845

Locations: 🇺🇸
Johns Hopkins Univ / School of Hygiene & Public Health, Baltimore, Maryland, United States
🇺🇸
Vanderbilt Univ Hosp, Nashville, Tennessee, United States
🇺🇸
Univ of Washington / Pacific Med Ctr, Seattle, Washington, United States

SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy

Phase 1

Completed

Conditions: Meningitis, Cryptococcal
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00000677

Locations: 🇺🇸
Ohio State Univ Med Ctr, Columbus, Ohio, United States
🇺🇸
Dr Robert Larsen, Los Angeles, California, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States

and more 25 locations

Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine

Completed

Conditions: HIV Infections
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 250

Registration Number: NCT00000828

Locations: 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
🇺🇸
UCLA Med Ctr / Pediatric, Los Angeles, California, United States
🇺🇸
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States

and more 26 locations

Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1000

Registration Number: NCT00000787

Locations: 🇺🇸
SUNY / Health Sciences Ctr at Brooklyn, Brooklyn, New York, United States

A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS

Phase 3

Completed

Conditions: HIV Infections
Pneumonia, Pneumocystis Carinii

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 290

Registration Number: NCT00000640

Locations: 🇺🇸
Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
🇺🇸
Methodist Hosp. of Indiana, Indianapolis, Indiana, United States
🇺🇸
Massachusetts General Hospital ACTG CRS, Boston, Massachusetts, United States

and more 29 locations

The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00006442

Locations: 🇺🇸
Michael S. Saag, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy